The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

The U.S currently does not have any large-scale commercial production of the isotope Mo-99 used for nuclear imaging. It is critical to more 40,000 nuclear imaging exams each day, representing about 80% of all diagnostic molecular imaging procedures.  

It is estimated that up to one-third of the U.S. population does not have a primary care provider.

The system provides long-term, wireless monitoring of muscle activity and function. Experts are hopeful that it could have utility in multiple healthcare settings. 

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

The announcement will come as welcome news, as nuclear medicine departments in numerous regions have been grappling with shortages of Mo-99 and Tc-99m.

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

More detailed estimations of lesion size could give providers greater insight into how to best manage a patient’s treatment plan. 

Screening uptake for younger women has been steadily rising for years. Consequently, so have cancer rates among the population.